Investor desk
Investors should track partnership announcements and pipeline signals from ACR Convergence.
← Back to Events
Tier 1 Global Networking: High IMMUNOLOGY 107 DAYS AWAY
ACR Convergence — 2026 — Orlando, US
ACR Convergence 2026 Exhibitor Application and Agreement Thank you for applying to exhibit at ACR Convergence 2026, taking place November 6-11, 2026, with exhibition dates of November 8-10, 2026, at Orange County Convention Center in Orlando, FL. This agreement is between the
Presentation data updated Jul 22, 2026, 2:31 AM UTC
Why This Event Matters
ACR Convergence 2026 Exhibitor Application and Agreement Thank you for applying to exhibit at ACR Convergence 2026, taking place November 6-11, 2026, with exhibition dates of November 8-10, 2026, at Orange County Convention Center in Orlando, FL.
Industry impact
ACR Convergence 2026 Exhibitor Application and Agreement Thank you for applying to exhibit at ACR Convergence 2026, taking place November 6-11, 2026, with exhibition dates of November 8-10, 2026, at Orange County Convention Center in Orlando, FL.
Market implications
Expect signals on pricing, formulary strategy, and partnership economics in US markets.
Regulatory implications
FDA and CMS policy on evidence generation and real-world data often surface at leadership forums.
Investor implications
Investors should track partnership announcements and pipeline signals from ACR Convergence.
Competitive implications
Competitive positioning among immunology players is a core theme — compare with prior editions.
Event Significance
Tier-1 industry catalyst
30 /100 composite
ACR Convergence is a targeted immunology forum where specialty pipeline readouts and BD conversations drive near-term positioning decisions. Primary driver: speaker calibre and KOL density.
- Speaker quality 14/20
Plenary and late-breaker slots attract global KOLs — high signal for clinical and regulatory teams.
- Company participation 0/20
Smaller exhibitor set — focus on disclosed presenters rather than floor traffic.
- Historical influence 10/20
Some historical catalysts; compare readouts against last cycle.
- Media coverage 6/20
Niche coverage — subscribe for direct abstract alerts.
- Pipeline relevance 0/20
Early science or services-focused — lower near-term PDUFA linkage.
Key Takeaways
Key Themes
immunologyPipeline announcements
Key Markets
US Americas
Key Opportunities
Partnership dealsLicensing discussionsVendor selection
Timeline & Milestones
- Pre-event intelligence Upcoming
Abstract discovery in progress; monitor Key Data tab.
- Conference opens Nov 6, 2026 Upcoming
Live readouts, late-breakers, and partnership announcements.
- Live coverage window Upcoming
Nova editorial monitors confirmed data releases.
- Conference closes Nov 11, 2026 Upcoming
Post-event recap, competitive takeaways, and trial updates.
BD teams Investors & analysts Regulatory leaders
Executive Summary
C-level briefACR Convergence 2026 Exhibitor Application and Agreement Thank you for applying to exhibit at ACR Convergence 2026, taking place November 6-11, 2026, with exhibition dates of November 8-10, 2026, at Orange County Convention Center in Orlando, FL.
Primary audience: BD teams · Investors & analysts · Regulatory leaders
Analyst Watch
Regulatory affairs
FDA and CMS policy on evidence generation and real-world data often surface at leadership forums.
Competitive intelligence
Competitive positioning among immunology players is a core theme — compare with prior editions.
vs. Prior Editions
| Edition | Presentations | Companies |
|---|---|---|
| ACR Convergence (current) | 0 | 0 |
| ACRP 2026 Annual (2026) | 1 | 0 |
Competitive Landscape
Company map →Competitive positioning among immunology players is a core theme — compare with prior editions.
Coverage & Analysis
No coverage articles yet. Check back closer to the event.
Related News & Research
Research hub →Event Intelligence Summary
Standalone summaries for ACR Convergence — optimized for research and AI retrieval.
Executive Summary
ACR Convergence 2026 Exhibitor Application and Agreement Thank you for applying to exhibit at ACR Convergence 2026, taking place November 6-11, 2026, with exhibition dates of November 8-10, 2026, at Orange County Convention Center in Orlando, FL.
Analyst View
ACR Convergence 2026 Exhibitor Application and Agreement Thank you for applying to exhibit at ACR Convergence 2026, taking place November 6-11, 2026, with exhibition dates of November 8-10, 2026, at Orange County Convention Center in Orlando, FL.
Investor View
Investors should track partnership announcements and pipeline signals from ACR Convergence.
BD View
BD teams should prioritize partnership and licensing conversations at ACR Convergence.
Key Facts
- Event
- ACR Convergence
- Focus
- immunology
- Region
- US Americas
- Location
- Orlando, US
Ask Nova AI
AI-assisted answers grounded in NovaPharmaNews intelligence
Answers use retrieved site intelligence plus AI synthesis. Verify critical decisions with primary sources.
Frequently Asked Questions
What is ACR Convergence?
ACR Convergence is a immunology industry conference for executives, clinical leaders, and investors.
Who attends ACR Convergence?
Typical attendees include pharma executives, BD teams, investors, and regulatory professionals focused on immunology.
Why is ACR Convergence important?
ACR Convergence influences partnership timing and policy debates affecting immunology markets for the next 12–18 months.
Where is ACR Convergence held?
ACR Convergence is held in Orlando, US.
What should investors watch at ACR Convergence?
Track partnership announcements, pipeline readouts, and management commentary on immunology catalysts.
What BD opportunities exist at ACR Convergence?
BD teams use ACR Convergence for licensing, co-development, and vendor selection across immunology.
How does ACR Convergence compare with other pharma conferences?
ACR Convergence is a tier-1 global congress for immunology — compare with peer events in the same vertical.
How do I get NovaPharmaNews coverage of ACR Convergence?
Subscribe to event alerts on this page for pre-event briefs, live coverage, and post-event analysis.